top of page

As a Result of the American Rescue Plan, Insulin Prices Drops Drastically in Pennsylvania

By Ken Knickerbocker


Due to the American Rescue Plan, the $1.9 trillion economic stimulus bill passed by Congress and signed into law in March of 2021, the nation’s three major insulin makers have significantly dropped their prices for insulin in Pennsylvania as of January 1, writes Isabel Soisson for The Keystone.

Eli Lilly, Sanofi, and Novo Nordisk, which together make up around 90 percent of the market, are now all officially offering price caps and savings programs that allow individuals to get some of their most widely-used insulin products for just $35 per month.


Comments


bottom of page